A young person with Duchenne muscular dystrophy died ... gene therapy delandistrogene moxeparvovec (Elevidys), Sarepta ...

after acknowledging the sudden death of a patient with Duchenne muscular dystrophy (DMD) following treatment with the company’s marketed gene therapy. The patient, whom Sarepta described as a ...

In March, Sarepta Therapeutics, Inc. SRPT shared an update on Elevidys (delandistrogene moxeparvovec-rokl), the only approved gene therapy ... especially after the recent patient death due to ...